Elsevier

Bone

Volume 21, Issue 5, November 1997, Pages 379-383
Bone

Original article
Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women

https://doi.org/10.1016/S8756-3282(97)00178-6Get rights and content

Abstract

In order to analyze the role of the estrogen receptor (ER) gene allelic polymorphisms on bone mineral density (BMD), 173 pre- and postmenopausal women were divided into four groups according to their menstrual status (group A: premenopausal women; group B: late premenopausal women; group C: postmenopausal women who had menopause for 5 years or less; and group D: postmenopausal women who had menopause for more than 5 years), and the relationship between ER gene polymorphism and lumbar spine BMD, the percent annual change in BMD and biochemical markers were studied. The restriction fragment length polymorphism (RFLPs) were represented as Xx (XbaI) and Pp (PvuII), with upper case and lower case letters signifying the absence or presence of restriction sites, respectively. In group A, the Xx genotype had significantly higher BMD (p < 0.01) than the xx genotype, but the difference was lost in groups B, C, and D. Because the percent annual change in BMD of group A was 0.052% and was not statistically different among genotypes, it is suggested that RFLP by Xba I is closely linked with peak bone mass that was attained during the subject's late thirties. In group B, serum N-region osteocalcin (N-OC) levels and the percent annual change in BMD showed a significantly larger increase than that of group A, indicating postmenopausal bone loss had commenced. Because the N-OC level of the Xx genotype was significantly higher than that of the xx genotype (p < 0.05), and the percent annual change in BMD of the Xx genotype showed a tendency to increase (p = 0.072), it is suggested that the high BMD of the Xx genotype is rapidly lost during menopausal transition. There were no significant relationships between RFLP and BMD in groups C and D, and between RFLP by PvuII and BMD. The present study suggests that the Xx genotype is involved in accretion of BMD during young adulthood, but the effect was lost during menstrual transition.

References (33)

  • P. Garnero et al.

    Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women

    J Bone Miner Res

    (1995)
  • M. Hatori et al.

    The effects of walking at the anaerobic threshold level on vertebral bone loss in postmenopausal women

    Calcif Tissue Int

    (1993)
  • F.G. Hustmyer et al.

    Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus

    J Clin Invest

    (1994)
  • P.J. Kelly et al.

    Changes in axial bone density with age: A twin study

    J Bone Miner Res

    (1993)
  • S. Kobayashi et al.

    Association of bone mineral density with polymorphism of estrogen receptor gene

    J Bone Miner Res

    (1996)
  • K.S. Korach

    Insights from the study of animals lacking a functional estrogen receptor

    Science

    (1994)
  • Cited by (149)

    • Causes of low peak bone mass in women

      2018, Maturitas
      Citation Excerpt :

      Thereafter, several other studies found similar associations in other populations [14,15]. In premenopausal women, it was reported that the ERα gene XbaI polymorphism was associated with BMD [14]. However, a more recent study showed that this relationship only occurred in association with the ERα gene PvuII polymorphism and not with the ERα gene XbaI polymorphism, whereby women with dominant (PP) genotypes have higher average lumbar spine BMD values than those with recessive (pp) genotypes [16].

    • Association of estrogen receptor alpha and interleukin-10 gene polymorphisms with endometriosis in a Chinese population

      2009, Fertility and Sterility
      Citation Excerpt :

      The present study also confirmed a close correlation between polymorphisms of ERα-XbaI and endometriosis and the X allele as a risk factor of endometriosis. Similar findings were described by Mizunuma et al. (28), who demonstrated that premenopausal women with the Xx genotype had significantly higher bone mineral density than those with other genotypes, suggesting that the Xx genotype of the ERα gene was more dependent on estrogen levels. Endometriosis is known to be an estrogen-dependent disorder, physiologically or pharmacologically induced by a decrease of serum estrogen levels, which is associated with regression of several diseases (29) such as breast cancer, endometrial cancer, obesity, multiple sclerosis, adenomyosis (30), leiomyomas, and endometrial cancer (31).

    • Genetic Determinants of Bone Mass and Osteoporotic Fracture

      2008, Principles of Bone Biology: Volume 1-2, Third Edition
    View all citing articles on Scopus
    View full text